mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.3 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.3 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.3 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.3 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.3 |